RT234
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for RT234, covering 2025-09-22 to 2026-04-06. Get the full timeline:
Most recent: Clinical Trial Update: A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension [Phase 2]